Influence of Age and Type 1 Diabetes Mellitus on Serological Test for Celiac Disease in Children
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Serological tests of tissue transglutaminase (TTG) and deamidated gliadin (DGP) antibodies for celiac disease diagnosis show conflicting correlation with histology in young children and in type 1 diabetes mellitus (T1DM). Tests' ability to predict histology and cutoff values based on age and T1DM was evaluated. Methods: A retrospective study of children who had celiac serological tests between 6/1/2002 and 12/31/2014 at a pediatric hospital. Results: TTG IgA displayed similar results in predicting histology between <4.0 and ≥4.0 years age groups with sensitivity 98% and 93%, and specificity 88% and 86%, respectively. In children <4.0 years old, sensitivity for DGP antibodies was 100% and specificity 94%; in ≥4.0 years age groups, sensitivity was 60%, 88% for DGP IgA and IgG and specificity 95%, 96%, respectively. TTG IgA had low specificity in patients with T1DM compared with non-T1DM, 42% vs. 91%. Positive TTG IgA with normal histology was associated with higher T1DM prevalence at 36% compared with negative tests at 4%. Finally, the TTG IgA cutoff value was higher in T1DM at 36 vs. 16.3 units in non-T1DM. DGP IgG cutoff showed similar values between age groups; TTG IgA and DGP IgA cutoffs were lower in <4.0 years at 8.3 and 11.9 units than ≥4.0 years at 23.4 and 19.9, respectively. Conclusion: TTG IgA is sufficient for the <4.0 years age group and DGP antibodies had no advantage over TTG IgA in older children. The cutoff value to determine a positive TTG IgA should be higher for children with T1DM.
Abstract
Purpose: Serological tests of tissue transglutaminase (TTG) and deamidated gliadin (DGP) antibodies for celiac disease diagnosis show conflicting correlation with histology in young children and in type 1 diabetes mellitus (T1DM). Tests' ability to predict histology and cutoff values based on age and T1DM was evaluated. Methods: A retrospective study of children who had celiac serological tests between 6/1/2002 and 12/31/2014 at a pediatric hospital. Results: TTG IgA displayed similar results in predicting histology between <4.0 and ≥4.0 years age groups with sensitivity 98% and 93%, and specificity 88% and 86%, respectively. In children <4.0 years old, sensitivity for DGP antibodies was 100% and specificity 94%; in ≥4.0 years age groups, sensitivity was 60%, 88% for DGP IgA and IgG and specificity 95%, 96%, respectively. TTG IgA had low specificity in patients with T1DM compared with non-T1DM, 42% vs. 91%. Positive TTG IgA with normal histology was associated with higher T1DM prevalence at 36% compared with negative tests at 4%. Finally, the TTG IgA cutoff value was higher in T1DM at 36 vs. 16.3 units in non-T1DM. DGP IgG cutoff showed similar values between age groups; TTG IgA and DGP IgA cutoffs were lower in <4.0 years at 8.3 and 11.9 units than ≥4.0 years at 23.4 and 19.9, respectively. Conclusion: TTG IgA is sufficient for the <4.0 years age group and DGP antibodies had no advantage over TTG IgA in older children. The cutoff value to determine a positive TTG IgA should be higher for children with T1DM.
참고문헌 (35)
- Lundin KE, "Coeliac disease-from genetic and immunological studies to clinical applications", Scand J Gastroenterol, 50, pp.708~717 (2015)
- Megiorni F, "HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition : practical implications of the HLA molecular typing", J Biomed Sci, 19, pp.88~ (2012)
- Caio G, "Celiac disease : a comprehensive current review", BMC Med, 17, pp.142~ (2019)
- Gujral N, "Celiac disease: prevalence, diagnosis, pathogenesis and treatment", World J Gastroenterol, 18, pp.6036~6059 (2012)
- Singh P, "Global prevalence of celiac disease : systematic review and meta-analysis", Clin Gastroenterol Hepatol, 16, pp.823~836 (2018)
- Rubio-Tapia A, "The prevalence of celiac disease in the United States", Am J Gastroenterol, 107, pp.1538~1544 (2012)
- Book L, "Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families", Am J Gastroenterol, 98, pp.377~381 (2003)
- Castro-Antunes MM, "Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil", Clinics(Sao Paulo), 66, pp.227~231 (2011)
- Akirov A, "Co-occurrence of type 1 diabetes mellitus and celiac disease", World J Diabetes, 6, pp.707~714 (2015)
- Not T, "Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus", Diabetologia, 44, pp.151~155 (2001)
- Holmes GK, "Screening for coeliac disease in type 1 diabetes", Arch Dis Child, 87, pp.495~498 (2002)
- Holmes GK, "Coeliac disease and Type 1 diabetes mellitus-the case for screening", Diabet Med, 18, pp.169~177 (2001)
- Caja S, "Antibodies in celiac disease : implications beyond diagnostics", Cell Mol Immunol, 8, pp.103~109 (2011)
- Rostom A, "The diagnostic accuracy of serologic tests for celiac disease: a systematic review", Gastroenterology, 128(4 Suppl 1), pp.S38~S46 (2005)
- Arigliani M, "Coeliac disease in infants: antibodies to deamidated gliadin peptide come first! Ital", J Pediatr, 43, pp.70~ (2017)
- Lammi A, "Development of gliadin-specific immune responses in children with HLA-associated genetic risk for celiac disease", Scand J Gastroenterol, 51, pp.168~177 (2016)
- Basso D, "New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis", Clin Chim Acta, 412, pp.1662~1667 (2011)
- Lagerqvist C, "Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age", J Pediatr Gastroenterol Nutr, 47, pp.428~435 (2008)
- Mozo L, "Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients", J Pediatr Gastroenterol Nutr, 55, pp.50~55 (2012)
- Sakly W, "Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis", Clin Res Hepatol Gastroenterol, 36, pp.598~603 (2012)
- Volta U, "Deamidated gliadin peptide antibodies as a routine test for celiac disease : a prospective analysis", J Clin Gastroenterol, 44, pp.186~190 (2010)
- Ludvigsson JF, "Symptoms and signs in individuals with serology positive for celiac disease but normal mucosa", BMC Gastroenterol, 9, pp.57~ (2009)
- Kurppa K, "Antibodies against deamidated gliadin peptides in early-stage celiac disease", J Clin Gastroenterol, 45, pp.673~678 (2011)
- Tsouka A, "Celiac disease alone and associated with type 1 diabetes mellitus", J Pediatr Gastroenterol Nutr, 61, pp.297~302 (2015)
- Pall H, "Young age at diagnosis of type 1 diabetes is associated with the development of celiac disease-associated antibodies in children living in Newfoundland and Labrador, Canada", Children(Basel), 2, pp.403~411 (2015)
- Castellaneta S, "High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes : a prospective study", Diabetes Care, 38, pp.760~766 (2015)
- Chan AW, "Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients", Pediatrics, 107, pp.E8~ (2001)
- Matteucci E, "Screening for coeliac disease in families of adults with Type 1 diabetes based on serological markers", Diabetes Nutr Metab, 14, pp.37~42 (2001)
- Waisbourd-Zinman O, "Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus", Dig Dis Sci, 57, pp.1314~1320 (2012)
- Rinawi F, "Elevated anti-tissue transglutaminase antibodies in children newly diagnosed with type 1 diabetes do not always indicate coeliac disease", Acta Paediatr, 108, pp.149~153 (2019)
- Liu E, "Fluctuating transglutaminase autoantibodies are related to histologic features of celiac disease", Clin Gastroenterol Hepatol, 1, pp.356~362 (2003)
- Hagopian W, "TEDDY Study Group. Co-occurrence of type 1 diabetes and celiac disease autoimmunity", Pediatrics, 140, pp.e20171305~ (2017)
- Maglio M, "Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine", Diabetes, 58, pp.1578~1584 (2009)
- Ludvigsson JF, "The Oslo definitions for coeliac disease and related terms", Gut, 62, pp.43~52 (2013)
- Boyd JC., "Defining laboratory reference values and decision limits: populations, intervals, and interpretations", Asian J Androl, 12, pp.83~90 (2010)